Literature DB >> 1586722

Molecular abnormalities of a phosphoglycerate kinase variant generated by spontaneous mutation.

M Maeda1, E V Bawle, R Kulkarni, E Beutler, A Yoshida.   

Abstract

A new case of X chromosome-linked phosphoglycerate kinase (PGK) abnormality is described. The male proband was mentally retarded, had behavior disorders, and displayed episodes of hemolytic anemia. The enzyme activity of red blood cells from the patient was about 10% of normal, and that of the cultured fibroblasts was about 50% of normal cells. The variant PGK was characterized by a lower affinity for the substrates, reduced thermostability, and increased anodal electrophoretic mobility. The pH activity profile of the variant enzyme was different from that of normal. The amount of messenger RNA (mRNA) in the variant fibroblasts was comparable to that of normal fibroblasts. The mRNA coding for PGK was subjected to coupled reverse transcription followed by amplification by the polymerase chain reaction. Nucleotide sequence of the variant cDNA showed a point mutation, T/A----C/G transition, in exon 9 of the variant gene. No other mutation was found in all coding regions of the variant. The mutation should cause Cys----Arg substitution at the 315th position from the NH2-terminal Ser of PGK, and it created an additional Ava II (or isoschimatic) cleavage site in the variant gene. Because the variant gene was not detected in the proband's mother and siblings, it must have been generated by spontaneous mutation during oogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586722

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Myopathy and parkinsonism in phosphoglycerate kinase deficiency.

Authors:  Evangelia Sotiriou; Paul Greene; Sindu Krishna; Michio Hirano; Salvatore DiMauro
Journal:  Muscle Nerve       Date:  2010-05       Impact factor: 3.217

2.  Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy.

Authors:  Masato Tamai; Takeshi Kawano; Ryota Saito; Ken Sakurai; Yoshihiro Saito; Hisashi Yamada; Hiroyuki Ida; Masaharu Akiyama
Journal:  Int J Hematol       Date:  2014-06-17       Impact factor: 2.490

3.  Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.

Authors:  J P Hossle; M de Boer; R A Seger; D Roos
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

4.  Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses.

Authors:  Angel L Pey; Maristella Maggi; Giovanna Valentini
Journal:  J Inherit Metab Dis       Date:  2014-05-17       Impact factor: 4.982

5.  Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency.

Authors:  Laurent R Chiarelli; Simone M Morera; Paola Bianchi; Elisa Fermo; Alberto Zanella; Alessandro Galizzi; Giovanna Valentini
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

6.  Protein Stability, Folding and Misfolding in Human PGK1 Deficiency.

Authors:  Giovanna Valentini; Maristella Maggi; Angel L Pey
Journal:  Biomolecules       Date:  2013-12-18

7.  A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population.

Authors:  Virginia Garcia-Solaesa; Pablo Serrano-Lorenzo; Maria Antonia Ramos-Arroyo; Alberto Blázquez; Inmaculada Pagola-Lorz; Mercè Artigas-López; Joaquín Arenas; Miguel A Martín; Ivonne Jericó-Pascual
Journal:  Genes (Basel)       Date:  2019-10-10       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.